(Q38120647)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Emerging evidence on the pathobiology of mucositis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Emma Bateman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rachel J. Gibson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Raj G. Nair

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Andrea Stringer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Roger Yazbeck

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Noor Al-Dasooqi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Stephen T Sonis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Nicole Blijlevens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Richard M Logan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sharon Elad

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rajesh V Lalla

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

11 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

Supportive Care in Cancer

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

3233-3241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00520-013-1900-x

4 March 2020

exact match

0 references

cites work

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Updated clinical practice guidelines for the prevention and treatment of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

The pathobiology of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Intestinal toxicity induced by 5-fluorouracil in pigs: a new preclinical model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the Dark Agouti rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

New thoughts on the pathobiology of regimen-related mucosal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Apoptosis. Its significance in cancer and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Role of AMP-18 in oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

The extracellular matrix as a cell survival factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Methotrexate modulates tight junctions through NF-κB, MEK, and JNK pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

IL-1beta-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Intestinal permeability in the assessment of intestinal toxicity of cytotoxic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Effect of selective inhibitors of inflammation on oral mucositis: preclinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Inflammatory bowel disease: etiology and pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Contributions of mucosal immune cells to methotrexate-induced mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Oral RDP58 allows CPT-11 dose intensification for enhanced tumor response by decreasing gastrointestinal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Effects of intensity-modulated radiotherapy on human oral microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Molecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Bacterial substitution of coagulase-negative staphylococci for streptococci on the oral mucosa after hematopoietic cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Mucositis: The impact, biology and therapeutic opportunities of oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Systematic review of agents for the management of gastrointestinal mucositis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Tumor control versus adverse events with targeted anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Mucosal injury from targeted anti-cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Genome-wide association studies and prediction of normal tissue toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

A deletion polymorphism in glutathione-S-transferase mu (GSTM1) and/or theta (GSTT1) is associated with an increased risk of toxicity after autologous blood and marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Personalized medicine for mucositis: Bayesian networks identify unique gene clusters which predict the response to gamma-D-glutamyl-L-tryptophan (SCV-07) for the attenuation of chemoradiation-induced oral mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00520-013-1900-X

21 January 2018

12 December 2020

The nature and control of infections in patients with acute leukemia.

1 reference

12 December 2020

Efficacy and safety of trastuzumab as a single agent in heavily pretreated patients with HER-2/neu-overexpressing metastatic breast cancer.

1 reference

12 December 2020

The burdens of cancer therapy

1 reference

12 December 2020

Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting

1 reference

12 December 2020

Establishment of a Single-Dose Irinotecan Model of Gastrointestinal Mucositis

1 reference

12 December 2020

The gene expression sequence of radiated mucosa in an animal mucositis model

1 reference

12 December 2020

Nuclear factor κB (NFκB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes

1 reference

12 December 2020

Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer

1 reference

12 December 2020

Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy.

1 reference

12 December 2020

Proinflammatory cytokines cause NO*-dependent and -independent changes in expression and localization of tight junction proteins in intestinal epithelial cells

1 reference

12 December 2020

The correlation between the severity of radiotherapy-induced glossitis and endothelial cell injury in local tissues in a rat model.

1 reference

12 December 2020

Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats

1 reference

12 December 2020

Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report

1 reference

12 December 2020

Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters

1 reference

12 December 2020

Lymphocyte subsets, granulocyte-colony-stimulating factor responsiveness and post-stem cell transplantation infections: mucositis is the underestimated confounder?

1 reference

12 December 2020

Trastuzumab induces gastrointestinal side effects in HER2-overexpressing breast cancer patients

1 reference

12 December 2020

Opportunistic gram-negative bacillary infections in leukemia. Oral manifestations during myelosuppression

1 reference

12 December 2020

Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study

1 reference

12 December 2020

New frontiers in mucositis

1 reference

12 December 2020

Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer

1 reference

12 December 2020

An animal model for mucositis induced by cancer chemotherapy

1 reference

12 December 2020

Role of cytokines (TNF-α, IL-1β and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide

1 reference

12 December 2020

Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients

1 reference

12 December 2020

Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the rat

1 reference

12 December 2020

Apoptosis and the dilemma of cancer chemotherapy.

1 reference

12 December 2020

The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies.

1 reference

12 December 2020

Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders

1 reference

12 December 2020

Nuclear factor-κB (NF-κB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy

1 reference

12 December 2020

The role of oral microorganisms in cancer therapy

1 reference

12 December 2020

Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat.

1 reference

12 December 2020

A biological approach to mucositis

1 reference

12 December 2020

10.1007/S00520-013-1900-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23842598%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference